Literature DB >> 6805416

Pharmacology of brain epinephrine neurons.

R W Fuller.   

Abstract

Neurons that contain PNMT, the epinephrine-forming enzyme, have their cell bodies in brain stem regions in rat brain and send projections mainly into other brain stem areas, hypothalamus, and spinal cord. These neurons can be affected pharmacologically by various kinds of drugs. Epinephrine neuronal systems might play a part in some pharmacologic actions of MAO inhibitors and uptake inhibitors as well as alpha and beta agonists and antagonists. PNMT inhibitors currently represent the only means of modifying epinephrine neurons pharmacologically without also altering norepinephrine or dopamine neurons in brain. The continued study of drugs affecting epinephrine neurons should be useful in elucidating functions of these neurons. Drugs that affect epinephrine neurons may be of use in the treatment of hypertension, psychiatric disorders, neuroendocrine dysfunction, and possibly other diseases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805416     DOI: 10.1146/annurev.pa.22.040182.000335

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  12 in total

Review 1.  Catecholaminergic based therapies for functional recovery after TBI.

Authors:  Nicole D Osier; C Edward Dixon
Journal:  Brain Res       Date:  2015-12-19       Impact factor: 3.252

2.  The role of catecholamines in HIV neuropathogenesis.

Authors:  R Nolan; P J Gaskill
Journal:  Brain Res       Date:  2018-04-27       Impact factor: 3.252

3.  Effects of salbutamol upon performance on an operant screen for antidepressants.

Authors:  R T Dunn; J B Richards; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Lesions of the ventral noradrenergic bundle prevent the rise in blood pressure induced by social deprivation stress in the rat.

Authors:  S Montero; J A Fuentes; P Fernandez-Tome
Journal:  Cell Mol Neurobiol       Date:  1990-12       Impact factor: 5.046

5.  Molecular cloning and characterization of an L-epinephrine transporter from sympathetic ganglia of the bullfrog, Rana catesbiana.

Authors:  S Apparsundaram; K R Moore; M D Malone; H C Hartzell; R D Blakely
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

6.  Involvement of central alpha- and beta-adrenoceptors in the pressor response to electrical stimulation of the rostral ventrolateral medulla in rats.

Authors:  C Ward-Routledge; P Marshall; C A Marsden
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

7.  Phenylethanolamine N-methyltransferase-containing neurons in the limbic system of the young rat.

Authors:  E Mezey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  Behavioral effects of the inhibitors of phenylethanolamine-N-methyltransferase, LY 78335 and LY 134046, and their interactions with ethanol.

Authors:  M J Durcan; R G Lister; M Linnoila
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Evidence for the presence of a non-catecholamine, clonidine-displacing substance in crude, methanolic extracts of bovine brain and lung.

Authors:  G Singh; J F Hussain; A MacKinnon; C M Brown; D A Kendall; V G Wilson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

10.  Molecular recognition of physiological substrate noradrenaline by the adrenaline-synthesizing enzyme PNMT and factors influencing its methyltransferase activity.

Authors:  Nyssa Drinkwater; Christine L Gee; Munish Puri; Kevin R Criscione; Michael J McLeish; Gary L Grunewald; Jennifer L Martin
Journal:  Biochem J       Date:  2009-08-27       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.